Each time semaglutide dose increases, expect glucose to drop further Proactively reduce basal insulin by 10% with each semaglutide escalation Continue daily glucose monitoring through titration Step 5: Maintenance phase (after reaching target semaglutide dose)
According to the Summary of Product Characteristics (SmPC) approved by the Medicines and Healthcare products Regulatory Agency (MHRA), serious but less common adverse effects can include pancreatitis, gallbladder disease, hypoglycaemia (particularly when used with insulin or sulfonylureas), and allergic reactions
Editors: Brunton, L., Hilal-Dandan, R., & Knollmann, B
In some cases, it simply means the plan needs to begin somewhere else
Research is investigating whether it can support heart function, particularly in certain metabolic or heart conditions
Looking Ahead: The Path to Patient-Centric Care and Safety The legal challenges facing Ozempic serve as a catalyst for advancing patient-centric care models that prioritize safety, informed choice, and shared decision-making